Unveiling Cerebrospinal Fluid Protein Biomarkers in Pediatric Acute Lymphoblastic Leukemia Using a Proximity Extension Assay
Journal of Proteome Research · 06.11.2026 · 25 (11) · 6276-6288
DOI: 10.1021/acs.jproteome.6c00599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 10.10.2026. Verfasst von Mahshid Moballegh Nasery und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen4032, Hungary. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Proteomics, Biomarkers, Tumor, Cerebrospinal Fluid Proteins. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Nemzeti Kutat?si Fejleszt?si ?s Innov?ci?s Hivatal, Stipendium Hungaricum Scholarship, Nemzeti Kutatási Fejlesztési és Innovációs Hivatal.
Abstract (Originalsprache)
Acute lymphoblastic leukemia (ALL) is a heterogeneous pediatric malignancy where relapse and central nervous system (CNS) involvement remain critical challenges. We combined high-throughput proteomics and machine learning (ML) to identify cerebrospinal fluid (CSF) biomarkers for treatment response and CNS status. Proteomic profiling of 276 proteins was performed on 82 CSF samples from 41 pediatric patients with ALL at diagnosis (VD) and in remission (VR) using Olink’s proximity extension assay. Differentially abundant proteins (q-value < 0.05, |log2FC| > 0.5) were identified via the Wilcoxon test, and Random Forest, LASSO, and SVM-RFE algorithms were integrated to select key predictive proteins for remission status and CNS involvement. Validation was performed using Pan-Cancer Atlas data sets. Remission was characterized by changes in ADGRG1, KYNU, CCL17, CD5, CD27, CXCL9, CXCL11, FASLG, GZMA, and TNFRSF9 between the two visits. Furthermore, distinct proteins associated with CNS involvement were shown, with CXCL9 and MMP7 being differentially abundant between CNS involvement groups at both visits. Integrating Olink proteomics with ML identified molecular signatures in ALL that have the potential to be considered as biomarkers for monitoring treatment response and guiding personalized therapeutic strategies, shifting the focus toward Precision One Health approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen4032, Hungary.
- Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, Debrecen4032, Hungary.
- Department of Pediatrics, Division of Pediatric Hematology and Oncology, Faculty of Medicine, University of Debrecen, Debrecen4032, Hungary.
- Pediatric Center, Faculty of Medicine, Semmelweis University, Budapest1085, Hungary.
ORCID-Profile: Mahshid Moballegh Nasery, Éva Csősz
Förderung
- Nemzeti Kutat?si Fejleszt?si ?s Innov?ci?s Hivatal
- Stipendium Hungaricum Scholarship
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Zitieren
APA
Moballegh Nasery, M., Gergely, R., Kutszegi, N., Szegedi, I., Erdélyi, D. J., Kiss, C., & Csősz, É. (2026). Unveiling Cerebrospinal Fluid Protein Biomarkers in Pediatric Acute Lymphoblastic Leukemia Using a Proximity Extension Assay. Journal of Proteome Research, 25(11), 6276-6288. https://doi.org/10.1021/acs.jproteome.6c00599
Vancouver
Moballegh Nasery M, Gergely R, Kutszegi N, Szegedi I, Erdélyi DJ, Kiss C, et al. Unveiling Cerebrospinal Fluid Protein Biomarkers in Pediatric Acute Lymphoblastic Leukemia Using a Proximity Extension Assay. Journal of Proteome Research. 2026;25(11):6276-6288. doi:10.1021/acs.jproteome.6c00599
BibTeX
@article{MoballeghNasery2026,
author = {Moballegh Nasery, Mahshid and Gergely, Réka and Kutszegi, Nóra and Szegedi, Istvan and Erdélyi, Dániel János and Kiss, Csongor and Csősz, Éva},
title = {Unveiling Cerebrospinal Fluid Protein Biomarkers in Pediatric Acute Lymphoblastic Leukemia Using a Proximity Extension Assay},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {11},
pages = {6276--6288},
doi = {10.1021/acs.jproteome.6c00599}
}
EUVIMED